期刊文献+

泰拉菌素对猪呼吸道细菌病的治疗效果

原文传递
导出
摘要 将某生猪养殖场里面一栋产仔舍当中的原舍留养的即将断奶仔猪作为本次试验的研究对象,剔除僵弱,南北两列,高床养殖,将每1列(32头)视为1组,同时随机确定其中1组为对照组,另1组为试验组;对照组的仔猪常规灌服泰妙菌素、阿莫西林等药物,试验组的仔猪给予泰拉菌素(Draxxin),0.2mL/头,断奶当天颈部肌注;对比分析2组仔猪的咳嗽头数。另外,选择猪呼吸道细菌病刚发病的肉猪与发病一定时间的肉猪(共计38头),经过其它药物治疗无效后均采用泰拉菌素(Draxxin)治疗,0.025ml/kg体重,颈部肌注,观察两类肉猪的治疗效果。结果:(1)仔猪的预防效果。试验组仔猪的实际预防效果要显著优于对照组的仔猪(P<0.05),且泰拉菌素(Draxxin)在用药后前7d内的药物起效时间要显著优于对照组(P<0.05)。(2)肉猪的治疗效果。对于发病初期的肉猪给予泰拉菌素(Draxxin),其治愈率为95.0%(19/20),对于发病一段时间的肉猪给予泰拉菌素(Draxxin),其治愈率为66.7%(12/18),发病初期的肉猪治愈率要显著高于发病一段时间的肉猪的治愈率(P<0.01)。结论:本次试验研究结果表明,泰拉菌素(Draxxin)的药效能够在颈部肌肉注射点得到非常快速地释放,进而在肺内达到抑菌浓度,能够非常有效而且迅速地抑制猪呼吸道疾病的各种常见病原体。同时,泰拉菌素(Draxxin)无菌悬液具有非常优秀的药物代谢动力学模式,能够提供长时间(一般均为14d)的药效,往往单次给药便可以使得药效持续一个疗程。另外,泰拉菌素(Draxxin)作为一种新型抗生素,能够更加有效、更加快速地控制保育期与育肥期猪的呼吸道疾病。
作者 权转玲
出处 《当代畜牧》 2012年第9期47-48,共2页 Contemporary Animal Husbandry
  • 相关文献

参考文献7

二级参考文献64

  • 1Hoflack G, Maes D, Mateusen B, et al. Efficacy of tilmicosin phosphate in feed for the treatment of a clinical outbreak of Actinobacillus pleuropneumoniae infection in growing - finishing pigs[J]. Journal of Veterinary Medicine B, 2001, 48: 655- 664.
  • 2Chang C F, Yeh T M, Chou C C, etal. Antimicrobial susceptibility and plasmid analysis of Actinobacillus pleuropneumoniae isolated in Taiwan[J]. Veterinary microbiology, 2002, 84: 169-177.
  • 3Denise M, Alexandra R, Sandra L, et al. Antimicrobial re sistanee profile of Actinobacillus pleuropneu moniae and Actinobacillus porcitonsillarum[J]. Veterinary Microbiology, 2007, 122: 146-156.
  • 4Moor G,Basson R, Tonkinson L. Clinical field trails with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocidain swine[J]. Am J Vet Res, 1996, 48: 224- 228.
  • 5Moussa S D, Francois M, Mario J. Postantibiotic and physio logical effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens[J].International Journal of Antimicrobial Agents, 1999,12 : 229-237.
  • 6Hart FG, KilgoreRW, NutschRG,etal. Efficacy oftulath romycin in the treatment of respiratory disease in pigs caused by Actinobacillus pleuropneumoniae[J].Vet Rec, 2006, 158 (13) : 433.
  • 7Nanjiani I A, Mckelvie J, Benchaoui H A, etal. Evaluation of the therapeutic activity of tulathromycin against swine respiratory disease on farms in Europe[J]. Vet Ther, 2005, 6(2):203- 213.
  • 8George G Z , Daryl J H , Godfrey K M. The postantibiotic effect: a review of in vitro and in vivo data[J]. Ann Pharma cother, 1991, 25:153.
  • 9Novelli A, Mazzei T, Fallani S, et al. In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramyein [J].J Chemother, 1995, 7: 355.
  • 10Godinho K S,Keane S G,Nanjiani I A,et al. Minimum Inhibitory Concentrations of Tulathromycin against Respiratory Bacterial Pathogens Isolated from Clinical Cases in European Cattle and Swine and Variability Arising from Chang.es in vitro Methodology [J]. Vet Ther,2005,6(2) :113 -121.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部